Search

everythinglearnresearchcommunity

for

Search:↓

Deleting the p63 gene in certain cells causes problems in thymus development and severe hair loss in mice.

The document concludes that corticosteroids effectively treat vasculitis allergica in over 90% of cases, with long-term kidney issues being the main adverse outcome.

Early intervention and patient education are crucial for managing alopecia areata.

Treating skin conditions with both psychological and dermatological care improves patient outcomes and can save costs.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

A bull got very sick and had to be put down after eating hairy vetch for months.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Blocking LFA-1 prevents hair loss in mice.

Simvastatin reduces inflammation and promotes hair regrowth in alopecia areata.

Some skin lymphomas can look like common skin issues and need careful testing to diagnose correctly.

Using hair dye may slightly increase the risk of non-Hodgkin's lymphoma, especially with long-term use.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

An elderly woman's swollen, painful foot was found to be caused by a rare type of bone lymphoma, which improved with radiation treatment.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Geriatric Julia Creek dunnarts often suffer from reproductive and skin diseases, impacting conservation efforts.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Higher NLR, PLR, and MPV may help diagnose androgenetic alopecia.

Nonimmunosuppressive cyclosporines might treat skin diseases by affecting cell growth.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

The report suggests that hair loss in Cronkhite-Canada syndrome may be caused by alopecia areata incognita, as shown by a patient's improvement with treatment.

More dermatologists in an area are linked to better survival rates for melanoma.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.